Cas:1095208-56-2 [2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate manufacturer & supplier

Chemical Name:[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

CAS.NO:1095208-56-2

Synonyms:3-(2-chlorophenylcarbamoyl)-2′,4′-difluorobiphenyl-4-yl benzoate

Molecular Formula:C₂₆H₁₆ClF₂NO₃

Molecular Weight:463.86000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:58.89000

Exact Mass:463.07900

LogP:7.14070

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(2-chlorophenylcarbamoyl)-2′,4′-difluorobiphenyl-4-yl benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-chlorophenylcarbamoyl)-2′,4′-difluorobiphenyl-4-yl benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-chlorophenylcarbamoyl)-2′,4′-difluorobiphenyl-4-yl benzoate Use and application,3-(2-chlorophenylcarbamoyl)-2′,4′-difluorobiphenyl-4-yl benzoate technical grade,usp/ep/jp grade.

Related News: UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. 4-(4-{2-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-ethylamino}-naphthalen-1-ylazo)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 3-methyl-1-phenyl-decahydro-pyrido[1,2-d][1,4]diazepine suppliers The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease. N-(4-iodophenyl)-2-(4-nitrophenoxy)acetamide vendor & factory Its approval has since been called into question, however, and the head of the FDA is now calling for a federal investigation looking into interactions between agency staff and the biotech company.,UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms.